TickerInside
Connect your agent Copies a setup prompt for your AI assistant

VBK holdings and overlap

View as Markdown What changed
VBKVanguard Morningstar Small-Cap Growth ETFSmall Growth, Vanguard, 540 positions
Last close, 2026-09-04
$349.44 +0.01%
52-week range 282 to 366
Largest position
RVMD
1.15% of the fund, Revolution Medicines Inc.
Positions
540
9.2% in the ten largest
Cost per year
0.05%
$5 a year on $10,000
Assets
$44.3B
the whole fund, all share classes
Return, 3 years
+58.2%
cumulative, total return
Worst fall
-24.7%
peak to trough, 3 years, weekly closes

What does VBK hold, as of its issuer file of 2026-07-31?

VBK holds 540 positions as of the issuer file dated 2026-07-31. The three largest are Revolution Medicines Inc. at 1.15%, Natera Inc. at 1.11% and Credo Technology Group Holding Ltd. at 1.04%; no ten names make up even 15% of it.

RankCompanyWeightWeight bar
1 RVMD Revolution Medicines Inc. 1.15%
2 NTRA Natera Inc. 1.11%
3 CRDO Credo Technology Group Holding Ltd. 1.04%
4 CASY Casey's General Stores Inc. 0.98%
5 TWLO Twilio Inc. Class A 0.91%
6 FTI TechnipFMC plc 0.87%
7 CW Curtiss-Wright Corp. 0.81%
8 ATI Allegheny Technologies Inc. 0.78%
9 NVT nVent Electric plc 0.76%
10 CRS Carpenter Technology Corp. 0.75%
11 P Pure Storage Inc. Class A 0.74%
12 ALAB Astera Labs Inc. 0.73%
13 OKTA Okta Inc. 0.73%
14 XPO XPO Logistics Inc. 0.68%
15 WWD Woodward Inc. 0.65%
16 FTAI FTAI Aviation Ltd. 0.64%
17 SOFI SoFi Technologies Inc. 0.64%
18 FWONK Liberty Media Corp-Liberty Formula One 0.63%
19 RBA RB Global Inc. 0.62%
20 GH Guardant Health Inc. 0.62%
21 INCY Incyte Corp. 0.62%
22 ROKU Roku Inc. 0.58%
23 AFRM Affirm Holdings Inc. 0.58%
24 ENTG Entegris Inc. 0.55%
25 EME EMCOR Group Inc. 0.54%

Issuer file 35 days old on 2026-09-04, against a median of 1 across the funds with a page. Every one of the 540 positions with its weight is in the fund's JSON file. See which other ETFs hold RVMD, and at what weight.

What does VBK duplicate?

The fund nearest to VBK is SMMD: the two hold 57.8% of their weight in common, in the 474 companies both own, and 76.4% of VBK itself is also held there. Owning VBK alongside the funds at the top of this table means about half of the weight is held twice.

FundOverlap by weightOf VBK held thereOf that fund in VBKCompanies in bothOverlap bar
SMMD 57.8% 76.4% 31.2% 474
ISCG 53.4% 62.9% 60.3% 400
VB 44.4% 100.0% 44.4% 539
IVOO 43.7% 46.9% 47.5% 163
SPMD 43.4% 47.4% 48.4% 164
MDY 43.3% 47.4% 48.4% 164
MDYG 43.1% 44.4% 72.2% 147
IVOG 43.0% 43.9% 71.4% 146
VXF 39.0% 88.9% 39.0% 501
ISCB 37.5% 67.6% 37.9% 460
QVMM 37.1% 38.0% 45.1% 129
SCHA 36.0% 49.5% 37.5% 383

From each issuer's latest file. Check VBK against any fund in the ETF overlap calculator · how overlap is measured.

What adds something different to VBK?

CQQQ shares 0% of weight with VBK and its weekly returns correlate with it at 0.38 over three years. The table lists the covered funds with the least in common with VBK, least shared weight first and, among equals, lowest correlation.

Cost, returns and risk

Expense ratio0.05%
Dividend yield0.44%
Total return, 1 year18.2%
Total return, 3 years cumulative58.2%
Total return, 5 years cumulative24.0%
Volatility, annualised19.5%
Worst fall, 3 years-24.7%
Beta against SPY, 3 years of weekly returns1.15
Weight in the ten largest positions9.2%
Largest single position1.2%
Assets, whole fund across share classes$44.3B

Expense ratio, yield and assets are reference data; every other figure is computed here from weekly closes.

How it moves with the market

AgainstCorrelation, 3 yearsCovariance, annualised, in percent squared
SPY0.85usually in step239
QQQ0.78often in step297

Weekly total returns. What the bands mean · why the covariance is printed.

Year by year

YearTotal return
202615.9%
20258.5%
202416.5%
202321.4%
2022-28.4%

One year

VBK 118 SPY 118
2025-09-122026-09-04
VBK rebased to 100 a year ago, weekly closes, prices through 2026-09-04.

Where to go next

Holdings from the issuer file published 2026-07-31. Prices through 2026-09-04. How every figure here is produced. Measurements, not investment advice.